News
A community trial has shown that the data-driven, fall-detecting wearable robot developed at Nanyang Technological University requires less physiotherapist assistance.
Powered by conversational AI, the tool aims to plug Hong Kong's palliative care workforce gap – with fewer than one specialist per 100,000 people – as advance medical directive legislation takes effect in May 2026.
The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.
Emerging Technologies
Debra Beauregard, director of medical intelligence and innovation at San Diego-based Rady Children's Health, joins MobiHealthNews to discuss partnering with digital health companies.
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.
A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.
The free virtual event will bring together healthcare, technology and policy stakeholders to discuss digital transformation, AI, rural broadband and advocacy.
Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.